Nonrisk-adapted Sequential Intravesical Gemcitabine and Docetaxel for Nonmuscle-invasive Bladder Cancer: The Time Is Now

Nonrisk-adapted Sequential Intravesical Gemcitabine and Docetaxel for Nonmuscle-invasive Bladder Cancer: The Time Is Now

Saved in:
Bibliographic Details
Published in:The Journal of urology Vol. 210; no. 1; pp. 5 - 7
Main Authors: Steinberg, Ryan L, O'Donnell, Michael A, Packiam, Vignesh T
Format: Journal Article
Language:English
Published: United States 01-07-2023
Subjects:
Administration, Intravesical
BCG Vaccine - therapeutic use
Deoxycytidine
Docetaxel - therapeutic use
Gemcitabine
Humans
Neoplasm Invasiveness
Urinary Bladder Neoplasms - drug therapy
intravesical
gemcitabine
docetaxel
administration
non-muscle invasive bladder neoplasms
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Scholarly Journals-1
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0022-5347
1527-3792
1527-3792
DOI:10.1097/JU.0000000000003438